Back
CRISPR Therapeutics AG Vs. Intellia Therapeutics Industry Stock Comparison
Buy
66
CRSP
CRISPR Therapeutics AG
Last Price:
56.19
Seasonality Move:
18.28%
Sell
45
NTLA
Intellia Therapeutics
Last Price:
26.24
Seasonality Move:
33.25%
Buy
66
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $56.22. The Score for CRSP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- CRSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $26.22. The Score for NTLA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $56.22
The current trend is relatively stagnant and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $26.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing slight buying pressure.
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.69 | Sell |
Relative Strength Index (14 RSI): | 47.02 | Sell |
Chaikin Money Flow: | 885602 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.68 - 56.9) | Buy |
Bollinger Bands (100): | (56.93 - 76.01) | Sell |
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 62.46 | Buy |
Chaikin Money Flow: | 117641 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.24 - 24.92) | Buy |
Bollinger Bands (100): | (23.55 - 29.45) | Sell |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.78 | Buy |
20-day SMA: | 54.94 | Buy |
50-day SMA: | 62.33 | Sell |
200-day SMA: | 59.32 | Sell |
8-day EMA: | 55.47 | Buy |
20-day EMA: | 56.17 | Buy |
50-day EMA: | 60.58 | Sell |
200-day EMA: | 61.45 | Sell |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.26 | Buy |
20-day SMA: | 23.39 | Buy |
50-day SMA: | 24.93 | Buy |
200-day SMA: | 29.22 | Sell |
8-day EMA: | 25.36 | Buy |
20-day EMA: | 24.39 | Buy |
50-day EMA: | 24.9 | Buy |
200-day EMA: | 29.74 | Sell |
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.03 per share, a decrease this year of $2.50 per share, and an increase next year of $1.15 per share.
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.26 per share, and a decrease next year of $0.19 per share.
CRISPR Therapeutics AG Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intellia Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |